COM:MADRIGALPHARMA
Madrigal Pharmaceuticals
- Stock
Last Close
329.24
22/11 21:00
Market Cap
7.58B
Beta: -
Volume Today
532.84K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | ||||||||||||
cost of revenue | 527K - | |||||||||||
gross profit | -527K - | |||||||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 15.70M - | 15.75M 0.30% | 13.39M 14.95% | 9.29M 30.63% | 7.67M 17.42% | 15.29M 99.34% | 22.65M 48.09% | 21.86M 3.46% | 37.32M 70.68% | 48.13M 28.97% | 108.15M 124.70% | |
selling general and administrative expenses | 15.70M - | 15.75M 0.30% | 13.39M 14.95% | 9.29M 30.63% | 7.67M 17.42% | 15.29M 99.34% | 22.65M 48.09% | 21.86M 3.46% | 37.32M 70.68% | 48.13M 28.97% | 108.15M 124.70% | |
research and development expenses | 71.86M - | 68.20M 5.09% | 54.22M 20.51% | 15.93M 70.61% | 24.39M 53.07% | 25.39M 4.10% | 72.32M 184.86% | 184.81M 155.53% | 205.16M 11.01% | 245.44M 19.63% | 271.82M 10.75% | |
other expenses | 350K - | 200K 42.86% | 100K - | 273K 173% | ||||||||
cost and expenses | 87.56M - | 83.95M 4.12% | 67.61M 19.46% | 25.22M 62.69% | 32.06M 27.11% | 40.68M 26.89% | 94.97M 133.45% | 206.67M 117.61% | 242.48M 17.33% | 293.57M 21.07% | 380.50M 29.61% | |
operating expenses | 87.56M - | 83.95M 4.12% | 67.61M 19.46% | 25.22M 62.69% | 32.06M 27.11% | 40.68M 26.89% | 94.97M 133.45% | 206.67M 117.61% | 242.48M 17.33% | 293.57M 21.07% | 379.97M 29.43% | |
interest expense | 2.63M - | 2.21M 16.07% | 1.06M 51.99% | 1.16M 9.71% | 558K 52.06% | 7.67M 1,274.73% | 11.02M 43.71% | 3.96M - | 12.71M 220.69% | |||
ebitda | -87.04M - | -83.28M 4.33% | -66.95M 19.61% | -25.22M 62.32% | -32.06M 27.11% | -40.68M 26.89% | -94.97M 133.45% | -206.67M 117.61% | -242.48M 17.33% | -291.39M 20.17% | -379.97M 30.40% | |
operating income | -87.56M - | -83.95M 4.12% | -67.61M 19.46% | -25.22M 62.69% | -32.06M 27.11% | -40.68M 26.89% | -94.97M 133.45% | -206.67M 117.61% | -242.48M 17.33% | -293.57M 21.07% | -380.50M 29.61% | |
depreciation and amortization | 516K - | 673K 30.43% | 662K 1.63% | 156 99.98% | 77K 49,258.97% | 96K 24.68% | 112K 16.67% | 471K 320.54% | 405K 14.01% | 2.19M 439.51% | 527K 75.88% | |
total other income expenses net | -2.63M - | -2.21M 16.07% | -1.06M 51.99% | -1.16M 9.73% | 350K 130.06% | 200K 42.86% | 11.02M 5,412% | 4.43M 59.82% | 636K 85.64% | -1.78M 379.72% | 6.87M 485.95% | |
income before tax | -90.19M - | -86.16M 4.47% | -68.67M 20.30% | -26.39M 61.57% | -31.15M 18.06% | -32.81M 5.32% | -83.95M 155.85% | -202.24M 140.92% | -241.85M 19.58% | -295.35M 22.12% | -373.63M 26.50% | |
income tax expense | -373 - | -635K 170,141.29% | 7.87M 1,339.53% | -11.14M 241.48% | -4.80M 56.90% | -768K 84% | 3.96M 616.15% | |||||
net income | -90.19M - | -86.16M 4.47% | -68.67M 20.30% | -26.39M 61.57% | -31.15M 18.06% | -32.81M 5.32% | -72.81M 121.91% | -197.44M 171.17% | -241.08M 22.10% | -299.31M 24.16% | -373.63M 24.83% | |
weighted average shs out | 2.03M - | 2.81M 38.76% | 171.01K 93.92% | 5.20M 2,943.44% | 12.24M 135.27% | 14.80M 20.84% | 15.39M 4.04% | 15.45M 0.34% | 16.54M 7.05% | 17.14M 3.64% | 18.69M 9.05% | |
weighted average shs out dil | 2.03M - | 2.81M 38.76% | 171.01K 93.92% | 5.20M 2,943.44% | 12.24M 135.27% | 14.80M 20.84% | 15.39M 4.04% | 15.45M 0.34% | 16.54M 7.05% | 17.14M 3.64% | 18.69M 9.05% | |
eps | -44.48 - | -30.62 31.16% | -401.56 1,211.43% | -5.07 98.74% | -2.54 49.90% | -2.22 12.60% | -4.73 113.06% | -12.78 170.19% | -14.58 14.08% | -17.47 19.82% | -19.99 14.42% | |
epsdiluted | -44.48 - | -30.62 31.16% | -401.56 1,211.43% | -5.07 98.74% | -2.54 49.90% | -2.22 12.60% | -4.73 113.06% | -12.78 170.19% | -14.58 14.08% | -17.47 19.82% | -19.99 14.42% |
All numbers in (except ratios and percentages)